Stone Ridge Asset Management LLC Meridian Bioscience Inc Transaction History

Stone Ridge Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$13.54 - $26.41 $601,609 - $1.17 Million	-44,432 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$5.57 - $11.5 $7,798 - $16,100	1,400 Added 3.25%	44,432 $373,000
Q3 2019 Nov 08, 2019	BUY	$9.17 - $12.01 $21,091 - $27,623	2,300 Added 5.65%	43,032 $408,000
Q2 2019 Aug 06, 2019	BUY	$10.88 - $17.6 $90,032 - $145,640	8,275 Added 25.5%	40,732 $484,000
Q1 2019 May 14, 2019	SELL	$15.51 - $17.61 $103,761 - $117,810	-6,690 Reduced 17.09%	32,457 $572,000
Q4 2018 Feb 14, 2019	BUY	$14.52 - $19.72 $20,502 - $27,844	1,412 Added 3.74%	39,147 $680,000
Q3 2018 Nov 06, 2018	BUY	$14.85 - $16.35 $2,970 - $3,270	200 Added 0.53%	37,735 $562,000
Q2 2018 Aug 13, 2018	SELL	$13.8 - $16.8 $11,799 - $14,364	-855 Reduced 2.23%	37,535 $597,000
Q4 2017 Feb 14, 2018	BUY	$13.55 - $15.8 $520,184 - $606,562	38,390	38,390 $537,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Stone Ridge Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Stone Ridge Asset Management LLC with notifications on news.